J&J Gave Doctors Kickbacks for Prescribing Their Drugs!

[youtube=https://www.youtube.com/watch?v=pAVJWxUq1rA]

• Published on Jan 29, 2014           
  In the shady world of American pharmaceuticals, there exists something known as “off-label” use, where drugs are marketed for other uses beside the one the FDA approved them for. Recently, Johnson & Johnson paid out $2.2 billion for paying doctors and pharmacists to sell their anti-psychotic drug, Risperdal, to elderly people with dementia. The Resident (aka Lori Harfenist) discusses.

end